IL-15 is a cousin of IL-2, but it is believed to be more targeted than the latter. Both drugs are immunotherapeutic,attempting to kickstart the body’s natural immune system into fighting the cancer naturally. Each tries to increase and activate lymphocyites which house Natural Kill Cells. I’m not making this up; Natural Killer Cellsis actually what they are called. And although they sound like murderous psychotics, and to some degree they are, they are on our side. Like the body’s own mob hit men.

Kidney cancer patient Chris Battle shares his experiences as he undergoes a new Phase I trial with the drug IL-15.

Take a few minutes to read this article from the Cancer Network website: http://www.cancernetwork.com/conference-reports/aacr2012/content/article/10165/2055542 This is why ACKC is working so hard on our lobbying efforts this year – to be sure that millions of dollars of funding available for kidney cancer research doesn’t get eliminated from the federal budget. PLEASE contact your US Senators [...]

ACKC is working to lobby Members of Congress to continue funding kidney cancer research. Through this campaign, I have had an opportunity to speak with many Congressional staffers and educate them about the incidence of kidney cancer – and you can do the same thing! Use the “Send a Letter” feature on this website to [...]

A piece that might be of interest to those of you on dialysis: http://www.nytimes.com/2012/03/28/health/policy/fda-approves-new-anemia-drug.html?scp=5&sq=kidney&st=cse //